Fred E Cooperrider

Array ( [id] => 5710470 [patent_doc_number] => 20060051815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Methods of treating smooth muscle cell disorders' [patent_app_type] => utility [patent_app_number] => 11/166669 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31888 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051815.pdf [firstpage_image] =>[orig_patent_app_number] => 11166669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028917 [patent_doc_number] => 20070270364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Helicases' [patent_app_type] => utility [patent_app_number] => 11/570754 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9139 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270364.pdf [firstpage_image] =>[orig_patent_app_number] => 11570754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856952 [patent_doc_number] => 07375212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Modulation of Aurora B expression' [patent_app_type] => utility [patent_app_number] => 11/136815 [patent_app_country] => US [patent_app_date] => 2005-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27267 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375212.pdf [firstpage_image] =>[orig_patent_app_number] => 11136815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8006067 [patent_doc_number] => 08084434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Runx2 isoforms in angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/587344 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 22110 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084434.pdf [firstpage_image] =>[orig_patent_app_number] => 11587344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224246 [patent_doc_number] => 20050261233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Modulation of glucose-6-phosphatase translocase expression' [patent_app_type] => utility [patent_app_number] => 11/111288 [patent_app_country] => US [patent_app_date] => 2005-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37997 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261233.pdf [firstpage_image] =>[orig_patent_app_number] => 11111288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135963 [patent_doc_number] => 20050180982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Cadherin-11 expression, an assay and treatment for cellular invasiveness' [patent_app_type] => utility [patent_app_number] => 11/108215 [patent_app_country] => US [patent_app_date] => 2005-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10006 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20050180982.pdf [firstpage_image] =>[orig_patent_app_number] => 11108215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349284 [patent_doc_number] => 20090004645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Methods for Identifying Genes that Mediate a Response of a Living Cell to an Agent' [patent_app_type] => utility [patent_app_number] => 11/578216 [patent_app_country] => US [patent_app_date] => 2005-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13970 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004645.pdf [firstpage_image] =>[orig_patent_app_number] => 11578216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5166090 [patent_doc_number] => 20070287677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/594659 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8968 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20070287677.pdf [firstpage_image] =>[orig_patent_app_number] => 10594659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583789 [patent_doc_number] => 07851452 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Methods of use of bcl-6-derived nucleotides to induce apoptosis' [patent_app_type] => utility [patent_app_number] => 10/593578 [patent_app_country] => US [patent_app_date] => 2005-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11309 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851452.pdf [firstpage_image] =>[orig_patent_app_number] => 10593578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927893 [patent_doc_number] => 20080167256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Cancer Therapy Via the Inhibition of Skp-2 Expression' [patent_app_type] => utility [patent_app_number] => 11/547492 [patent_app_country] => US [patent_app_date] => 2005-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10884 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167256.pdf [firstpage_image] =>[orig_patent_app_number] => 11547492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4579335 [patent_doc_number] => 07833987 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Small synthetic RNA, a method of preparing the same and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/598700 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6974 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833987.pdf [firstpage_image] =>[orig_patent_app_number] => 10598700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694738 [patent_doc_number] => 20060154885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Modulation of SLC26A2 expression' [patent_app_type] => utility [patent_app_number] => 11/072846 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21147 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154885.pdf [firstpage_image] =>[orig_patent_app_number] => 11072846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740559 [patent_doc_number] => 20080234212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Materials and Methods for Treatment of Allergic Disease' [patent_app_type] => utility [patent_app_number] => 10/590680 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13365 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234212.pdf [firstpage_image] =>[orig_patent_app_number] => 10590680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652155 [patent_doc_number] => 20080039411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Use Of Resistin Antisense Oligonucleotides And/Or Sirna Molecules In The Treatment Of Rheumatoid Arthritis' [patent_app_type] => utility [patent_app_number] => 10/590635 [patent_app_country] => US [patent_app_date] => 2005-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6480 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039411.pdf [firstpage_image] =>[orig_patent_app_number] => 10590635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004566 [patent_doc_number] => 20070202134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Muc1 Antagonist Enhancement of Death Receptor Ligand-Induced Apoptosis' [patent_app_type] => utility [patent_app_number] => 10/598295 [patent_app_country] => US [patent_app_date] => 2005-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6188 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202134.pdf [firstpage_image] =>[orig_patent_app_number] => 10598295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198703 [patent_doc_number] => 20070298021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Methods and Compositions for the Treatment or Prevention of Secondary Ischemic Injury' [patent_app_type] => utility [patent_app_number] => 10/589842 [patent_app_country] => US [patent_app_date] => 2005-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9583 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298021.pdf [firstpage_image] =>[orig_patent_app_number] => 10589842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5819965 [patent_doc_number] => 20060024278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Methods and products related to the production of inner ear hair cells' [patent_app_type] => utility [patent_app_number] => 11/041907 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 33749 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024278.pdf [firstpage_image] =>[orig_patent_app_number] => 11041907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136624 [patent_doc_number] => 20050181400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Modulation of eIF4E-BP1 expression' [patent_app_type] => utility [patent_app_number] => 11/042768 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27816 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181400.pdf [firstpage_image] =>[orig_patent_app_number] => 11042768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6944738 [patent_doc_number] => 20050196787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Modulation of eIF4E-BP2 expression' [patent_app_type] => utility [patent_app_number] => 11/042899 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23930 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196787.pdf [firstpage_image] =>[orig_patent_app_number] => 11042899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596840 [patent_doc_number] => 20060160758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Antisense modulation of CD40 ligand expression' [patent_app_type] => utility [patent_app_number] => 11/039632 [patent_app_country] => US [patent_app_date] => 2005-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27598 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160758.pdf [firstpage_image] =>[orig_patent_app_number] => 11039632 [rel_patent_id] =>[rel_patent_doc_number] =>)